MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s43441-024-00615-8

Медицинская библиотека · Therapeutic innovation & regulatory science · 2024

Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework.

Izem Rima, Zuber Emmanuel, Daizadeh Nadia, Bretz Frank, Sverdlov Oleksandr, Edrich Pascal, Branson Janice, Degtyarev Evgeny, Sfikas Nikolaos, Hemmings Robert

СтатьяПеревод пока не подготовлен

Аннотация

While industry and regulators' interest in decentralized clinical trials (DCTs) is long-standing, the Covid-19 pandemic accelerated and broadened the adoption and experience with these trials. The key idea in decentralization is bringing the clinical trial design, typically on-site, closer to the patient's experience (on-site or off-site). Thus, potential benefits of DCTs include reducing the burden of participation in trials, broadening access to a more diverse population, or using innovative endpoints collected off-site. This paper helps researchers to carefully evaluate the added value and the implications of DCTs beyond the operational aspects of their implementation. The proposed approach is to use the ICH E9(R1) estimand framework to guide the strategic decisions around each decentralization component. Furthermore, the framework can guide the process for clinical trialists to systematically consider the implications of decentralization, in turn, for each attribute of the estimand. We illustrate the use of this approach with a fully DCT case study and show that the proposed systematic process can uncover the scientific opportunities, assumptions, and potential risks associated with a possible use of decentralization components in the design of a trial. This process can also highlight the benefits of specifying estimand attributes in a granular way. Thus, we demonstrate that bringing a decentralization component into the design will not only impact estimators and estimation but can also correspond to addressing more granular questions, thereby uncovering new target estimands.

Для цитирования: Izem Rima, Zuber Emmanuel, Daizadeh Nadia, Bretz Frank, Sverdlov Oleksandr, Edrich Pascal, Branson Janice, Degtyarev Evgeny, Sfikas Nikolaos, Hemmings Robert. Decentralized Clinical Trials: Scientific Considerations Through the Lens of the Estimand Framework.. Therapeutic innovation & regulatory science. 2024. DOI: 10.1007/s43441-024-00615-8.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.